SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    California Assured That Interstate Cannabis Sales Would Not Incur Federal Penalties

    By

    California’s attorney general’s office has begun to explore the potential legal implications of allowing interstate cannabis trading, and whether it would expose California to risk of federal enforcement.

    According to documents obtained by Marijuana Moment, prominent local governments and cannabis industry groups have assured that California would not be at ‘significant risk’.

    California is now one of three states, also including Oregon and Washington State, to have passed laws allowing officials to conduct cross-border cannabis trade.

    READ MORE: New York Cannabis Businesses Face Another Set Back As Injunction Granted

    While Oregon and Washington require some form of federal reform or guidance to move ahead, California’s laws allows the Governor to do so if the attorney general determines that doing so would not incur the wrath of federal enforcers.

    The attorney general’s launched a review in January, and has now received a number of responses from organisations including Rural County Representatives of California (RCRC), the California State Association of Counties (CSAC) and the California Cannabis Authority (CCA).

    Each group has explicitly suggested that authorising interstate cannabis sales would not lead to federal enforcement action.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free